Enveric Biosciences
ENVB

Enveric Biosciences (ENVB) earnings history

Most recent quarter

Period end
Sep 30, 2025
EPS actual
−$10.81
EPS estimate
−$63.00
Revenue
$0.00
Reported
Nov 14, 2025

Earnings history

PeriodReportedEPS estimateEPS actualSurpriseRevenueFiling
Q3 2025Nov 14, 2025−$63.00−$10.81+82.84%$0.00SEC
Q2 2025Aug 14, 2025−$63.00−$11.64+81.52%$0.00SEC
Q1 2025May 14, 2025−$72.00−$14.64+79.67%$0.00SEC
Q4 2024Mar 28, 2025−$41.40−$57.96−40.00%$0.00SEC
Q3 2024Nov 14, 2024−$93.60−$43.20+53.85%$0.00SEC
Q2 2024Aug 12, 2024−$99.00−$41.40+58.18%$0.00SEC
Q1 2024May 15, 2024−$139.50−$109.80+21.29%$0.00SEC
Q4 2023Mar 26, 2024−$284.40−$262.80+7.59%$0.00SEC
Q3 2023Nov 13, 2023−$376.20−$234.00+37.80%$0.00SEC
Q1 2023May 15, 2023−$401.40−$415.80−3.59%$0.00SEC
Q3 2022Nov 14, 2022−$630.00−$561.60+10.86%$0.00
Q2 2022Aug 12, 2022−$675.00−$790.20−17.07%$0.00
Q4 2021Mar 31, 2022−$1,440.00−$2,790.00−93.75%$0.00

Quarterly revenue

Q4 2021
$0.00
Q2 2022
$0.00
Q3 2022
$0.00
Q1 2023
$0.00
Q3 2023
$0.00
Q4 2023
$0.00
Q1 2024
$0.00
Q2 2024
$0.00
Q3 2024
$0.00
Q4 2024
$0.00
Q1 2025
$0.00
Q2 2025
$0.00
Q3 2025
$0.00

Frequently asked questions

  • When did Enveric Biosciences (ENVB) last report earnings?

    Enveric Biosciences last reported on Nov 14, 2025, covering fiscal Q3 2025.

  • Did ENVB beat earnings estimates?

    Yes. Enveric Biosciences reported EPS of −$10.81 for Q3 2025 against a −$63.00 estimate — a 82.84% beat.

Earnings figures may be restated, revised or corrected by the issuer. Past results do not indicate future performance.

This page is for informational purposes only. Nothing on it is a recommendation, solicitation or offer to buy or sell any security, nor investment, legal or tax advice. Light Horse Securities Inc does not verify third-party data and is not responsible for its accuracy, completeness or timeliness.